Giancarlo Castaman Selected Research

recombinant factor XIII-A2

2/2022

Safety and effectiveness of recombinant factor XIII-A2 in congenital factor XIII deficiency: Real-world evidence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giancarlo Castaman Research Topics

Disease

82	Hemorrhage 04/2024 - 01/2003
69	Hemophilia A (Haemophilia) 04/2024 - 07/2007
21	von Willebrand Diseases (von Willebrand's Disease) 08/2022 - 01/2002
17	Hemophilia B (Haemophilia B) 10/2023 - 01/2008
9	Type 1 von Willebrand Disease 12/2020 - 01/2007
8	Thrombosis (Thrombus) 06/2023 - 09/2002
7	Venous Thromboembolism 06/2023 - 09/2002
7	Neoplasms (Cancer) 08/2022 - 11/2002
6	Type 3 von Willebrand Disease 07/2023 - 01/2005
6	Thrombocytopenia (Thrombopenia) 08/2022 - 04/2008
4	Joint Diseases (Joint Disease) 01/2021 - 02/2016
4	Type 2 von Willebrand Disease 01/2020 - 01/2009
4	Thrombophilia 03/2012 - 08/2002
3	Gaucher Disease (Gaucher's Disease) 11/2022 - 05/2015
3	Inflammation (Inflammations) 11/2022 - 04/2007
3	Multiple Myeloma 01/2016 - 11/2002
3	Afibrinogenemia (Fibrinogen Deficiency) 07/2015 - 10/2007
3	Inherited Blood Coagulation Disorders 09/2013 - 09/2008
3	Vascular System Injuries 09/2013 - 01/2003
3	Venous Thrombosis (Deep-Vein Thrombosis) 10/2003 - 08/2002
2	Body Weight (Weight, Body) 08/2023 - 01/2023
2	Hypersensitivity (Allergy) 07/2022 - 11/2021
2	Infections 01/2022 - 01/2020
2	Hemarthrosis 01/2020 - 02/2016
2	Liver Diseases (Liver Disease) 01/2020 - 10/2017
2	Menorrhagia 01/2020 - 04/2011
2	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 01/2018
2	Essential Thrombocythemia 01/2008 - 09/2002
2	Polycythemia Vera 01/2008 - 09/2002
1	Intracranial Thrombosis (Cerebral Thrombosis) 06/2023
1	Atrial Fibrillation 06/2023
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2023
1	Anaphylaxis (Anaphylactic Shock) 01/2023
1	Hypoprothrombinemias (Prothrombin Deficiency) 01/2023
1	Bone Resorption 11/2022
1	Craniocerebral Trauma (Head Injury) 11/2022
1	Intra-Abdominal Hypertension 11/2022
1	Thrombotic Microangiopathies 11/2022
1	Multiple Trauma (Multiple Injuries) 11/2022
1	Myocardial Infarction 11/2022

Drug/Important Bio-Agent (IBA)

45	Factor VIII (Coagulation Factor VIII)IBA 01/2024 - 02/2002
39	von Willebrand FactorIBA 07/2023 - 01/2002
15	emicizumabIBA 04/2024 - 01/2020
14	Factor IX (Coagulation Factor IX)FDA LinkGeneric 10/2023 - 12/2007
12	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2003
12	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 08/2022 - 01/2005
11	Hemostatics (Antihemorrhagics)IBA 01/2024 - 01/2013
11	Blood Coagulation Factors (Coagulation Factor)IBA 06/2023 - 09/2008
7	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2007
7	AnticoagulantsIBA 06/2023 - 09/2002
7	AntibodiesIBA 01/2023 - 10/2015
6	Monoclonal AntibodiesIBA 04/2024 - 01/2020
6	recombinant FVIIa (rFVIIa)FDA Link 03/2023 - 09/2017
5	AntigensIBA 01/2020 - 04/2003
5	Prothrombin (Factor II)IBA 11/2019 - 07/2004
4	Neutralizing AntibodiesIBA 01/2023 - 09/2013
4	Factor XI (Plasma Thromboplastin Antecedent)IBA 09/2013 - 12/2007
3	concizumabIBA 08/2023 - 11/2019
3	BESIBA 07/2023 - 01/2022
3	Factor VII (Proconvertin)IBA 07/2023 - 11/2021
3	Glucosylceramides (Glucocerebrosides)IBA 11/2022 - 05/2015
3	CytokinesIBA 01/2021 - 01/2016
3	Fibrinogen (Factor I)FDA Link 10/2019 - 07/2009
3	Nonsense Codon (Nonsense Mutation)IBA 01/2017 - 09/2012
3	factor V LeidenIBA 10/2013 - 09/2002
3	Protein CIBA 04/2007 - 08/2002
3	Factor V (Coagulation Factor V)IBA 02/2004 - 09/2002
2	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 10/2023 - 01/2021
2	lipoprotein-associated coagulation inhibitor (TFPI)IBA 08/2023 - 11/2019
2	CoagulantsIBA 01/2023 - 01/2019
2	AlbuminsIBA 01/2023 - 01/2016
2	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 01/2023 - 10/2017
2	IsoantibodiesIBA 01/2023 - 01/2021
2	sphingosyl beta-glucosideIBA 11/2022 - 01/2016
2	Platelet Glycoprotein GPIb-IX Complex (Glycoprotein Ib)IBA 10/2020 - 01/2009
2	RistocetinIBA 01/2020 - 07/2016
2	Thrombin FDA Link 11/2019 - 01/2019
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2019 - 03/2012
2	Factor VIIa (Activated Factor VII)IBA 09/2018 - 09/2017
2	EnzymesIBA 01/2016 - 05/2015
2	Glucosylceramidase (Glucocerebrosidase)IBA 01/2016 - 05/2015
2	von Willebrand factor drug combination factor VIIIIBA 06/2010 - 07/2007
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2024
1	SDMIBA 11/2023
1	TESIBA 11/2022
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 08/2022

Therapy/Procedure

32	Therapeutics 03/2024 - 07/2007
2	Intravenous Infusions 07/2023 - 01/2023
2	Arthroplasty 06/2023 - 01/2021
2	Replacement Arthroplasty 06/2023 - 01/2021
2	Tooth Extraction (Tooth Extractions) 11/2022 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2018 - 11/2016
2	Platelet Transfusion (Blood Platelet Transfusions) 01/2018 - 11/2016
2	Operative Surgical Procedures 02/2016 - 01/2008
2	Contraindications 07/2007 - 01/2005
1	Elective Surgical Procedures 10/2023
1	Minor Surgical Procedures (Minor Surgery) 03/2023
1	Subcutaneous Injections 01/2023
1	Aftercare (After-Treatment) 01/2023
1	Intravenous Administration 09/2022